Low-Cost, Broad-Spectrum Cancer Vaccine Targeting Human Papillomavirus Low- Cost, Broad- Spectrum Cancer Vaccine Targeting Human Papillomavirus
|Effective start/end date||5/11/22 → 3/31/23|
- HHS-NIH: National Cancer Institute (NCI): $130,027.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.